Complement factor C5a induces atherosclerotic plaque disruptions
Open Access
- 15 August 2014
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 18 (10) , 2020-2030
Abstract
Complement factor C5a and its receptor C5aR are expressed in vulnerable atherosclerotic plaques; however, a causal relation between C5a and plaque rupture has not been established yet. Accelerated atherosclerosis was induced by placing vein grafts in male apoE−/− mice. After 24 days, when advanced plaques had developed, C5a or PBS was applied locally at the lesion site in a pluronic gel. Three days later mice were killed to examine the acute effect of C5a on late stage atherosclerosis. A significant increase in C5aR in the plaque was detectable in mice treated with C5a. Lesion size and plaque morphology did not differ between treatment groups, but interestingly, local treatment with C5a resulted in a striking increase in the amount of plaque disruptions with concomitant intraplaque haemorrhage. To identify the potential underlying mechanisms, smooth muscle cells and endothelial cells were treated in vitro with C5a. Both cell types revealed a marked increase in apoptosis after stimulation with C5a, which may contribute to lesion instability in vivo. Indeed, apoptosis within the plaque was seen to be significantly increased after C5a treatment. We here demonstrate a causal role for C5a in atherosclerotic plaque disruptions, probably by inducing apoptosis. Therefore, intervention in complement factor C5a signalling may be a promising target in the prevention of acute atherosclerotic complications.Keywords
Funding Information
- Hartstichting (2010B029)
This publication has 47 references indexed in Scilit:
- Plaque Rupture Complications in Murine Atherosclerotic Vein Grafts Can Be Prevented by TIMP-1 OverexpressionPLOS ONE, 2012
- Complement Activation Product C5a Is a Selective Suppressor of TLR4-Induced, but Not TLR3-Induced, Production of IL-27(p28) from MacrophagesThe Journal of Immunology, 2012
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- Augmented Atherogenesis in LDL Receptor Deficient Mice Lacking Both Macrophage ABCA1 and ApoEPLOS ONE, 2011
- Complement in atherosclerosis: friend or foe?Journal of Thrombosis and Haemostasis, 2011
- C5a Enhances Dysregulated Inflammatory and Angiogenic Responses to Malaria In Vitro: Potential Implications for Placental MalariaPLOS ONE, 2009
- Activation by C5a of endothelial cell caspase 8 and cFLIPInflammation Research, 2009
- The Complement Anaphylatoxin C5a Induces Apoptosis in Adrenomedullary Cells during Experimental SepsisPLOS ONE, 2008
- The molecular mechanisms of the thrombotic complications of atherosclerosisJournal of Internal Medicine, 2008
- Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosisEuropean Heart Journal, 2005